FR3011009B1 - Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie - Google Patents
Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologieInfo
- Publication number
- FR3011009B1 FR3011009B1 FR1359249A FR1359249A FR3011009B1 FR 3011009 B1 FR3011009 B1 FR 3011009B1 FR 1359249 A FR1359249 A FR 1359249A FR 1359249 A FR1359249 A FR 1359249A FR 3011009 B1 FR3011009 B1 FR 3011009B1
- Authority
- FR
- France
- Prior art keywords
- pathology
- prevention
- treatment
- atopic dermatitis
- bacterial signature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1359249A FR3011009B1 (fr) | 2013-09-25 | 2013-09-25 | Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie |
| US15/024,683 US20160215326A1 (en) | 2013-09-25 | 2014-09-25 | Bacterial signature of atopic dermatitis and use thereof in the prevention and/or treatment of this pathology |
| PCT/EP2014/070574 WO2015044315A1 (fr) | 2013-09-25 | 2014-09-25 | Signature bactérienne de dermatite atopique et son utilisation dans la prévention et/ou le traitement de cette pathologie |
| EP14781106.1A EP3049533B1 (fr) | 2013-09-25 | 2014-09-25 | Signature bactérienne de la dermatite atopique et son utilisation dans la prévention et/ou le traitement de cette pathologie |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1359249A FR3011009B1 (fr) | 2013-09-25 | 2013-09-25 | Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3011009A1 FR3011009A1 (fr) | 2015-03-27 |
| FR3011009B1 true FR3011009B1 (fr) | 2016-11-25 |
Family
ID=49713257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1359249A Expired - Fee Related FR3011009B1 (fr) | 2013-09-25 | 2013-09-25 | Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20160215326A1 (fr) |
| EP (1) | EP3049533B1 (fr) |
| FR (1) | FR3011009B1 (fr) |
| WO (1) | WO2015044315A1 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009140550A2 (fr) | 2008-05-14 | 2009-11-19 | Dermtech International | Diagnostic de mélanome et de lentigo solaire par analyse d'acides nucléiques |
| JP2016528880A (ja) | 2013-06-18 | 2016-09-23 | プロダームアイキュー インコーポレイテッド | 皮膚細菌叢の解析に基づくカスタマイズしたスキンケア製品及びパーソナルケア製品 |
| CN107106429B (zh) | 2014-11-10 | 2021-06-29 | 宝洁公司 | 具有两种有益相的个人护理组合物 |
| MX376115B (es) | 2014-11-10 | 2025-03-07 | Procter & Gamble | Composiciones para el cuidado personal con dos fases benéficas. |
| US10966916B2 (en) | 2014-11-10 | 2021-04-06 | The Procter And Gamble Company | Personal care compositions |
| EP3346910A4 (fr) * | 2015-09-09 | 2019-05-15 | Ubiome Inc. | Procédé et système pour diagnostics dérivés du microbiome et agents thérapeutiques contre l'eczéma |
| EP4345725A3 (fr) | 2015-09-17 | 2024-06-19 | Prodermiq, Inc. | Prédiction de l'âge de la peau sur la base de l'analyse de la flore cutanée et des données de style de vie |
| CN110753966A (zh) | 2017-03-10 | 2020-02-04 | 普罗皮肤检测股份有限公司 | 基于皮肤菌群分析的定制化护肤产品和个人护理产品 |
| CN111212625B (zh) | 2017-10-20 | 2023-05-23 | 宝洁公司 | 气溶胶泡沫洁肤剂 |
| WO2019079405A1 (fr) | 2017-10-20 | 2019-04-25 | The Procter & Gamble Company | Nettoyant moussant en aérosol pour la peau |
| CA3090785A1 (fr) | 2018-02-14 | 2019-08-22 | John Daniel Dobak Iii | Nouveaux classificateurs de genes et leurs utilisations dans des cancers de la peau sans melanome |
| RU2692803C1 (ru) * | 2018-10-08 | 2019-06-27 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ прогнозирования степени тяжести атопического дерматита у детей с сопутствующим дисбактериозом кишечника |
| CN113015904B (zh) | 2018-11-29 | 2024-06-18 | 宝洁公司 | 用于筛选个人护理产品的方法 |
| JP2020182435A (ja) * | 2019-05-07 | 2020-11-12 | 学校法人慶應義塾 | アトピー性皮膚炎の診断方法 |
| FR3099770B1 (fr) * | 2019-08-05 | 2023-01-13 | Luxia Scient | Methode d’analyse de la perte de diversite bacterienne du microbiome intestinal humain |
| CN115398198A (zh) | 2020-03-24 | 2022-11-25 | 宝洁公司 | 用于测试皮肤样本的方法 |
| EP4251773A4 (fr) * | 2020-11-24 | 2024-10-30 | Dermtech, Inc. | Évaluation de la charge mutationnelle dans la peau |
| WO2022117442A1 (fr) | 2020-12-01 | 2022-06-09 | Evonik Operations Gmbh | Culture mixte synthétique ressemblant à un microbiome cutané |
| FR3121936A1 (fr) * | 2021-04-20 | 2022-10-21 | Naos Institute Of Life Science | Methode de criblage d’ingredients et de compositions topiques ecobiologiques, et son utilisation pour realiser un soin cosmetique de restauration du microbiote cutane |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008107275A (ja) * | 2006-10-27 | 2008-05-08 | Juntendo | アレルギー性皮膚炎の診断法 |
| US7919250B2 (en) * | 2007-07-31 | 2011-04-05 | New York University | Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions |
| US8906629B2 (en) * | 2009-12-03 | 2014-12-09 | Shiseido Company, Ltd. | Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator |
| JP5520246B2 (ja) * | 2011-02-25 | 2014-06-11 | 株式会社ファンケル | アトピー性皮膚炎の検査方法 |
| BR112015021755A2 (pt) * | 2013-03-07 | 2017-07-18 | Kane Biotech Inc | composições antimicrobianas e antibiofilmes e métodos de aplicação das mesmas |
| WO2015095241A2 (fr) * | 2013-12-16 | 2015-06-25 | Seres Health, Inc. | Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire |
-
2013
- 2013-09-25 FR FR1359249A patent/FR3011009B1/fr not_active Expired - Fee Related
-
2014
- 2014-09-25 EP EP14781106.1A patent/EP3049533B1/fr active Active
- 2014-09-25 US US15/024,683 patent/US20160215326A1/en not_active Abandoned
- 2014-09-25 WO PCT/EP2014/070574 patent/WO2015044315A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20160215326A1 (en) | 2016-07-28 |
| WO2015044315A1 (fr) | 2015-04-02 |
| EP3049533B1 (fr) | 2018-12-26 |
| FR3011009A1 (fr) | 2015-03-27 |
| EP3049533A1 (fr) | 2016-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR3011009B1 (fr) | Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie | |
| EP3720549A4 (fr) | Systèmes et procédés de traitement de patient | |
| EP3936095C0 (fr) | Détection d'infections microbiennes dans des plaies | |
| EP2931919A4 (fr) | Procédés et systèmes pour le traitement de polynucléotides | |
| SI3240554T1 (sl) | Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni | |
| EP2978373A4 (fr) | Système destiné à être utilisé dans le traitement de fractures vertébrales | |
| EP2948188A4 (fr) | Imagerie neuronale et traitement | |
| EP3262407C0 (fr) | Procédés et systèmes de traitement de cloisonnement | |
| MA39960A (fr) | Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer | |
| EP2836270A4 (fr) | Systèmes et procédés liés au traitement de la douleur dorsale | |
| PT2953969T (pt) | Anticorpos anti-il-17a e utilização dos mesmos no tratamento de distúrbios autoimunes e inflamatórios | |
| EP2954065A4 (fr) | Fractionnement et traitement d'analytes et d'autres espèces | |
| EP3519833A4 (fr) | Méthodes de pronostic et de traitement | |
| EP3166688C0 (fr) | Ligands de visualisation de tau et leurs utilisations dans le diagnostic et le traitement de tauopathies | |
| HRP20180671T1 (hr) | Pripravci za i postupci inhibiranja masp-1 i/ili masp-3 u liječenju paroksizmalne noćne hemoglobinurije | |
| EP2962092A4 (fr) | Procédés et systèmes de traitement micro-fluidique amélioré | |
| IL252418B (en) | Envenomation therapies and related pharmaceutical compositions, systems and kits | |
| EP2969010A4 (fr) | Utilisation de levocetirizine et de montelukast dans le traitement des maladies auto-immunes | |
| EP3365028A4 (fr) | Détection et traitement de caries et de microcavités avec des nanoparticules | |
| EP3576738A4 (fr) | Utilisation de gaboxadol dans le traitement des acouphènes | |
| EP3331984A4 (fr) | Systèmes et procédés de traitement d'allogreffe rapides | |
| EP2854910A4 (fr) | Niveaux de céramide dans le traitement et la prévention d'infections | |
| EP3259600C0 (fr) | Dosage diagnostique et traitement de la pré-éclampsie | |
| FR2999428B1 (fr) | Chitine ou derives de chitine pour utilisation dans la prevention et/ou le traitement de parasitoses | |
| MA42915A (fr) | Pyridines et leur utilisation dans le traitement du cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| ST | Notification of lapse |
Effective date: 20210506 |